Melita Sun Jung - May 1, 2024 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Business Officer
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Melita Sun Jung
Stock symbol
TERN
Transactions as of
May 1, 2024
Transactions value $
$0
Form type
4
Date filed
5/2/2024, 05:29 PM
Previous filing
May 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TERN Stock Option (Right to buy) Award $0 +475K $0.00 475K May 1, 2024 Common Stock 475K $5.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from May 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.